Previous studies have reported that 6RK73 suppresses oncogenic UCHL1 activation in breast cancer and delays the progression of renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion, particularly PRCC-TFE3 tRCC7. Here, PRCC is linked to renal cell carcinoma.